Norfloxacin suppresses Leptospira-induced inflammation through inhibiting p65 and ERK phosphorylation and NLRP3 inflammasome activation. (January 2022)
- Record Type:
- Journal Article
- Title:
- Norfloxacin suppresses Leptospira-induced inflammation through inhibiting p65 and ERK phosphorylation and NLRP3 inflammasome activation. (January 2022)
- Main Title:
- Norfloxacin suppresses Leptospira-induced inflammation through inhibiting p65 and ERK phosphorylation and NLRP3 inflammasome activation
- Authors:
- Xie, Xufeng
Zhang, Wenlong
Chen, Xi
Wu, Dianjun
Cao, Yongguo - Abstract:
- Abstract: Leptospirosis is a worldwide re-emerging zoonosis caused by pathogenic Leptospira . Inflammatory storms induced by Leptospira are the reason to induce immunoparalysis and organ failures. Antibiotics are still the current mainstream treatment for leptospirosis. In addition to their antibacterial action, the immunomodulatory function of antibiotics has been paid more and more attention. In this study, the role of norfloxacin on Leptospira -induced inflammation was investigated. Treatment with norfloxacin down-regulated Leptospira -induced IL-1β and TNF-α both in vivo and vitro models. Further study showed that norfloxacin inhibited Leptospira -induced phosphorylation of p65 and ERK. Norfloxacin also inhibited the Leptospira -induced NLRP3 inflammasome activation with the increased level of Na/K–ATPase Pump β1 subunit and decreased level of Kcnk6. These results indicated that norfloxacin suppressed Leptospira -induced inflammation through inhibiting p65 and ERK phosphorylation and NLRP3 inflammasome activation. Norfloxacin may be a potential candidate for suppressing inflammatory storms caused by Leptospira . Highlights: Nor suppresses Leptospira -induced inflammation. Nor inhibits the phosphorylation of p65 and ERK during Leptospira infection. Nor inhibits Leptospira -induced NLRP3 inflammasome activation. Nor up regulates the expression of Na/Kβ1 subunit, down regulates the expression of Kcnk6 during Leptospira infection.
- Is Part Of:
- Microbial pathogenesis. Volume 162(2022)
- Journal:
- Microbial pathogenesis
- Issue:
- Volume 162(2022)
- Issue Display:
- Volume 162, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 162
- Issue:
- 2022
- Issue Sort Value:
- 2022-0162-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-01
- Subjects:
- Leptospirosis -- Norfloxacin -- Inflammation -- NLRP3 inflammasome -- IL-1β
Pathogenic microorganisms -- Periodicals
Pathology, Molecular -- Periodicals
Communicable Diseases -- microbiology -- Periodicals
Communicable Diseases -- parasitology -- Periodicals
Micro-organismes pathogènes -- Périodiques
Pathologie moléculaire -- Périodiques
Electronic journals
616.9041 - Journal URLs:
- http://www.sciencedirect.com/science/journal/08824010 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0882-4010;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.micpath.2021.105315 ↗
- Languages:
- English
- ISSNs:
- 0882-4010
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5756.955000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20501.xml